Priming the Liver Endocytic Pathway to Accelerate Hepatobiliary Clearance of Nanoparticles
Top Cited Papers
- 21 February 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (9) , 7805-7816
Abstract
Prolonged hepatic accumulation represents a major obstacle for clinical translation of many nanomedicines, particularly for those not easily biodegradable. While many strategies such as PEGylation have been developed to reduce or delay the liver uptake of nanoparticles, strategies that expedite nanoparticle elimination after liver uptake are rarely reported. Herein, we report a broadly applicable strategy to accelerate hepatobiliary elimination of diverse nanoparticles through priming of the liver endocytic pathway. Inspired by our findings that smaller gold nanoparticles exhibit inherently faster hepatobiliary clearance due to size-dependent endocytic pathways, we discovered that inhibition of clathrin-mediated endocytosis (CME) significantly enhances nanoparticle exocytosis from hepatocytes and macrophages. Mechanistically, we found that CME inhibition alters nanoparticle intracellular trafficking, diverting endocytosed nanoparticles from the lysosomal pathway to the Golgi apparatus for faster exocytosis. Using the clinically approved drug chlorpromazine as a CME inhibitor, we demonstrated that priming the liver with chlorpromazine markedly accelerated hepatobiliary clearance and reduced hepatic retention of various nanoparticles ranging from inorganic to organic ones in mice. Moreover, in a murine tumor model, we showed that hepatic CME inhibition accelerated hepatobiliary elimination of the model nanomedicine without compromising its disease targeting efficacy. Our discovery highlights a versatile strategy for accelerating hepatobiliary elimination of nanoparticles, which is expected to synergize with previous strategies for overcoming nonspecific liver accumulation of nanomedicines.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFB3810300)
- National Natural Science Foundation of China (22275056)
- National Natural Science Foundation of China (32271434)
- GJYC program of Guangzhou (2024D01J0054)
This publication has 44 references indexed in Scilit:
- All Roads Lead to the Liver: Metal Nanoparticles and Their Implications for Liver HealthSmall, 2020
- Indocyanine Green–Coated Gold Nanoclusters for Photoacoustic Imaging and Photothermal TherapyAdvanced Therapeutics, 2019
- PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdvanced Drug Delivery Reviews, 2016
- Insight into nanoparticle cellular uptake and intracellular targetingJournal of Controlled Release, 2014
- PEGylation and Zwitterionization: Pros and Cons in the Renal Clearance and Tumor Targeting of Near‐IR‐Emitting Gold NanoparticlesAngewandte Chemie International Edition, 2013
- The transport pathways of polymer nanoparticles in MDCK epithelial cellsBiomaterials, 2013
- Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapyBiomaterials, 2012
- Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in ratsBiomaterials, 2010
- Alternate routes for drug delivery to the cell interior: Pathways to the Golgi apparatus and endoplasmic reticulum☆Advanced Drug Delivery Reviews, 2007
- Comparative Distribution, Excretion, and Metabolism of 14C-Labeled Quaternary Ammonium Compounds of Promazine, Chlorpromazine, and TriflupromazineJournal of Pharmaceutical Sciences, 1970